{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:28:51Z","timestamp":1785209331798,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bbi.2020.04.038","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:23:25Z","timestamp":1587165805000},"page":"878-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Modulating the immune response with the wake-promoting drug modafinil: A potential therapeutic approach for inflammatory disorders"],"prefix":"10.1016","volume":"88","author":[{"given":"Adriano","family":"Zager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2020.04.038_b0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(94)91976-3","article-title":"Time-dependent in vivo mesolimbic dopamine variations following antigenic challenge","volume":"664","author":"Lacosta","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2020.04.038_b0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0278-5846(88)90014-0","article-title":"Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil","volume":"12","author":"Bastuji","year":"1988","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.038_b0015","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinthera.2016.02.004","article-title":"Effects of modafinil and armodafinil in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials","volume":"38","author":"Kuan","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbi.2020.04.038_b0020","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nm.4133","article-title":"Activation of the reward system boosts innate and adaptive immunity","volume":"22","author":"Ben-Shaanan","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2020.04.038_b0025","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/s41467-018-05283-5","article-title":"Modulation of anti-tumor immunity by the brain's reward system","volume":"9","author":"Ben-Shaanan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2020.04.038_b0030","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/sleep\/27.6.1181","article-title":"What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications","volume":"27","author":"Boutrel","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2020.04.038_b0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A systematic review of modafinil: Potential clinical uses and mechanisms of action","volume":"67","author":"Ballon","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.038_b0040","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.euroneuro.2015.07.028","article-title":"Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review","volume":"25","author":"Battleday","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2020.04.038_b0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2020.04.038_b0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","article-title":"R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse","volume":"72","author":"Loland","year":"2012","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.bbi.2020.04.038_b0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/ml1002025","article-title":"SARs at the monoamine transporters for a novel series of modafinil analogues","volume":"2","author":"Cao","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbi.2020.04.038_b0060","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.038_b0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-010-1839-2","article-title":"Dopamine transporter-related effects of modafinil in rhesus monkeys","volume":"210","author":"Andersen","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2020.04.038_b0070","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbi.2020.04.038_b0075","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1097\/00001756-200111160-00032","article-title":"Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats","volume":"12","author":"de Saint Hilaire","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.bbi.2020.04.038_b0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbr.2006.10.016","article-title":"Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats","volume":"176","author":"Murillo-Rodriguez","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2020.04.038_b0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/ejn.13376","article-title":"The unique psychostimulant profile of (+\/-)-modafinil: investigation of behavioral and neurochemical effects in mice","volume":"45","author":"Mereu","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.038_b0090","article-title":"Roles of Adrenergic \u03b11 and Dopamine D1 and D2 Receptors in the Mediation of the Desynchronization Effects of Modafinil in a Mouse EEG Synchronization Model","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2020.04.038_b0095","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1523\/JNEUROSCI.1819-08.2008","article-title":"Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil","volume":"28","author":"Qu","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.038_b0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pnpbp.2018.07.019","article-title":"The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors","volume":"88","author":"Gonzalez","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.038_b0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/syn.10127","article-title":"Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity","volume":"46","author":"Stone","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.bbi.2020.04.038_b0110","first-page":"19","article-title":"Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study","volume":"27","author":"Gallopin","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2020.04.038_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.009","article-title":"Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex","volume":"82","author":"Gonzalez","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.038_b0120","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2165\/00003495-200868130-00003","article-title":"Approved and investigational uses of modafinil - An evidence-based review","volume":"68","author":"Kumar","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.bbi.2020.04.038_b0125","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2020.04.038_b0130","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/sleep\/30.11.1405","article-title":"Electrical coupling: Novel mechanism for sleep-wake control","volume":"30","author":"Garcia-Rill","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2020.04.038_b0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbr.2017.07.013","article-title":"Arousal and drug abuse","volume":"333","author":"Urbano","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2020.04.038_b0140","doi-asserted-by":"crossref","first-page":"12554","DOI":"10.1073\/pnas.0705087104","article-title":"Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling","volume":"104","author":"Urbano","year":"2007","journal-title":"P Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2020.04.038_b0145","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/sleep\/31.12.1647","article-title":"Modafinil Increases Arousal Determined by P13 Potential Amplitude: An Effect Blocked by Gap Junction Antagonists","volume":"31","author":"Beck","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2020.04.038_b0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuropharm.2013.04.019","article-title":"The psychostimulant modafinil enhances gap junctional communication in cortical astrocytes","volume":"75","author":"Liu","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2020.04.038_b0155","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.5665\/sleep.5854","article-title":"Impact of astroglial connexins on modafinil pharmacological properties","volume":"39","author":"Duchene","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2020.04.038_b0160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbr.2012.05.023","article-title":"Individual differences are critical in determining modafinil-induced behavioral sensitization and cross-sensitization with methamphetamine in mice","volume":"233","author":"Soeiro Ada","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2020.04.038_b0165","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1369-1600.2011.00341.x","article-title":"Addictive potential of modafinil and cross-sensitization with cocaine: a pre-clinical study","volume":"16","author":"Wuo-Silva","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbi.2020.04.038_b0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fphar.2016.00420","article-title":"Modafinil induces rapid-onset behavioral sensitization and cross-sensitization with cocaine in mice: implications for the addictive potential of modafinil","volume":"7","author":"Wuo-Silva","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2020.04.038_b0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fphar.2019.00211","article-title":"Participation of Dopamine D1 and D2 Receptors in the Rapid-Onset Behavioral Sensitization to Modafinil","volume":"10","author":"Wuo-Silva","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2020.04.038_b0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2012.07.039","article-title":"Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: Implications for addiction","volume":"235","author":"Shuman","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2020.04.038_b0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-002-1080-8","article-title":"Study of the addictive potential of modafinil in naive and cocaine-experienced rats","volume":"161","author":"Deroche-Gamonet","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2020.04.038_b0190","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1037\/a0031832","article-title":"Modafinil alone and in combination with low dose amphetamine does not establish conditioned place preference in male Sprague-Dawley rats","volume":"21","author":"Quisenberry","year":"2013","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2020.04.038_b0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2015.08.016","article-title":"Sex differences in dopamine binding and modafinil conditioned place preference in mice","volume":"155","author":"Bernardi","year":"2015","journal-title":"Drug Alcohol. Depen"},{"key":"10.1016\/j.bbi.2020.04.038_b0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","article-title":"Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study","volume":"70","author":"Dackis","year":"2003","journal-title":"Drug Alcohol. Depen"},{"key":"10.1016\/j.bbi.2020.04.038_b0205","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2020.04.038_b0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00952990600920425","article-title":"Modafinil and cocaine interactions","volume":"32","author":"Malcolm","year":"2006","journal-title":"Am. J. Drug Alcohol. Ab"},{"key":"10.1016\/j.bbi.2020.04.038_b0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2014.05.008","article-title":"Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study","volume":"141","author":"Verrico","year":"2014","journal-title":"Drug Alcohol Depen"},{"key":"10.1016\/j.bbi.2020.04.038_b0220","series-title":"The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders","author":"Mereu","year":"2013"},{"key":"10.1016\/j.bbi.2020.04.038_b0225","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuropharm.2014.02.002","article-title":"Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice","volume":"87","author":"Gonzalez","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2020.04.038_b0230","first-page":"7","article-title":"Attentional Control in Adolescent Mice Assessed with a Modified Five Choice Serial Reaction Time Task","author":"Ciampoli","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.bbi.2020.04.038_b0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuropharm.2017.04.037","article-title":"Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder","volume":"121","author":"Mereu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2020.04.038_b0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroscience.2014.08.014","article-title":"Short- and Long-Term Treatment with Modafinil Differentially Affects Adult Hippocampal Neurogenesis","volume":"278","author":"Brandt","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2020.04.038_b0245","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.expneurol.2013.07.021","article-title":"Caffeine and modafinil promote adult neuronal cell proliferation during 48 h of total sleep deprivation in rat dentate gyrus","volume":"248","author":"Sahu","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2020.04.038_b0250","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.pnpbp.2017.05.003","article-title":"The wake-promoting drug Modafinil prevents motor impairment in sickness behavior induced by LPS in mice: Role for dopaminergic D1 receptor","volume":"81","author":"Zager","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.038_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105809","article-title":"Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice","volume":"75","author":"Brand\u00e3o","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2020.04.038_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046599","article-title":"Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum","volume":"7","author":"Raineri","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2020.04.038_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140678","article-title":"Suppression of Locomotor Activity in Female C57Bl\/6J Mice Treated with Interleukin-1beta: Investigating a Method for the Study of Fatigue in Laboratory Animals","volume":"10","author":"Bonsall","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2020.04.038_b0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fncel.2018.00049","article-title":"Caffeine and modafinil ameliorate the neuroinflammation and anxious behavior in rats during sleep deprivation by inhibiting the microglia activation","volume":"12","author":"Wadhwa","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.038_b0275","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.3390\/molecules170910446","article-title":"Simple synthesis of modafinil derivatives and their anti-inflammatory activity","volume":"17","author":"Jung","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bbi.2020.04.038_b0280","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1097\/00001756-199812210-00038","article-title":"Modafinil prevents glutamate cytotoxicity in cultured cortical neurons","volume":"9","author":"Antonelli","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.bbi.2020.04.038_b0285","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2020.04.038_b0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02259133","article-title":"Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis","volume":"88","author":"Fuxe","year":"1992","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bbi.2020.04.038_b0295","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3940(99)00706-5","article-title":"A stereological study on the neuroprotective actions of acute modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse","volume":"275","author":"Aguirre","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2020.04.038_b0300","first-page":"301","article-title":"Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"25","author":"Xiao","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbi.2020.04.038_b0305","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00228393","article-title":"The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway","volume":"93","author":"Ueki","year":"1993","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bbi.2020.04.038_b0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00230442","article-title":"Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat","volume":"96","author":"Ueki","year":"1993","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bbi.2020.04.038_b0315","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11011-018-0378-0","article-title":"Neuroprotective effect of ethanol and Modafinil on focal cerebral ischemia in rats","volume":"34","author":"Abbasi","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbi.2020.04.038_b0320","first-page":"1","article-title":"Therapeutic effects of modafinil in ischemic stroke; possible role of NF-kappaB downregulation","author":"Yousefi-Manesh","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.bbi.2020.04.038_b0325","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.msard.2017.10.011","article-title":"Meta-analysis of the efficacy of modafinil versus placebo in the treatment of multiple sclerosis fatigue","volume":"19","author":"Shangyan","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.bbi.2020.04.038_b0330","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4088\/JCP.10m06708","article-title":"A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease","volume":"73","author":"Frakey","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.038_b0335","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pnpbp.2017.09.009","article-title":"Increased interferon-mediated immunity following in vitro and in vivo Modafinil treatment on peripheral immune cells","volume":"81","author":"Zager","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.038_b0340","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.smrv.2018.09.006","article-title":"Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy","volume":"43","author":"Szabo","year":"2019","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.bbi.2020.04.038_b0345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10787-017-0387-3","article-title":"Modafinil attenuates inflammation via inhibiting Akt\/NF-kappaB pathway in apoE-deficient mouse model of atherosclerosis","volume":"26","author":"Han","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bbi.2020.04.038_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104305","article-title":"Protective effects of modafinil administration on testicular torsion\/detorsion damage in rats","volume":"111","author":"Yousefi-Manesh","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbi.2020.04.038_b0355","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s43440-019-00054-5","article-title":"Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway","volume":"72","author":"Dejban","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbi.2020.04.038_b0360","doi-asserted-by":"crossref","first-page":"E330","DOI":"10.1097\/BRS.0000000000001287","article-title":"Dopamine D1 Receptor Agonist A-68930 Inhibits NLRP3 Inflammasome Activation, Controls Inflammation, and Alleviates Histopathology in a Rat Model of Spinal Cord Injury","volume":"1976) 41","author":"Jiang","year":"2016","journal-title":"Spine (Phila Pa"},{"key":"10.1016\/j.bbi.2020.04.038_b0365","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2020.04.038_b0370","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1567-5769(03)00100-0","article-title":"Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells","volume":"3","author":"Ghosh","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2020.04.038_b0375","first-page":"491","article-title":"Dopamine receptors modulate T lymphocytes via inhibition of cAMP-CREB signaling pathway","volume":"37","author":"Huang","year":"2016","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.bbi.2020.04.038_b0380","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00702-016-1640-4","article-title":"Dopamine, T cells and multiple sclerosis (MS)","volume":"124","author":"Levite","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.bbi.2020.04.038_b0385","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000049004","article-title":"Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism","volume":"9","author":"Saha","year":"2001","journal-title":"NeuroImmunoModulation"},{"key":"10.1016\/j.bbi.2020.04.038_b0390","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/157015911795596612","article-title":"The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders","volume":"9","author":"Buttarelli","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbi.2020.04.038_b0395","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1742-2094-9-203","article-title":"Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse","volume":"9","author":"Gaskill","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bbi.2020.04.038_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112686","article-title":"A novel approach to study markers of dopamine signaling in peripheral immune cells","volume":"476","author":"Gopinath","year":"2020","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbi.2020.04.038_b0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.03.020","article-title":"The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease","volume":"70","author":"Mackie","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.038_b0410","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbi.2019.06.006","article-title":"Dopamine-mediated immunomodulation affects choroid plexus function","volume":"81","author":"Castellani","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.038_b0415","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/jcp.25307","article-title":"The Involvement of Parasympathetic and Sympathetic Nerve in the Inflammatory Reflex","volume":"231","author":"Pereira","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbi.2020.04.038_b0420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.imlet.2016.08.006","article-title":"Neuro-immune interactions in the cholinergic anti-inflammatory reflex","volume":"178","author":"Reardon","year":"2016","journal-title":"Immunol. Lett."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119314953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119314953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:15:13Z","timestamp":1760170513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119314953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":84,"alternative-id":["S0889159119314953"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.04.038","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating the immune response with the wake-promoting drug modafinil: A potential therapeutic approach for inflammatory disorders","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}